IMAX Record Q3 Can't Lift Stock to Insider Exit Prices
IMAX reported record Q3 adjusted EPS of $2.21, crushing the $1.02 consensus by 116.4% with record revenue and 69% adjusted EBITDA margins. Yet the stock trades at $47.27, below the $51–$53 prices at w
IMAX Record Q3 Can't Lift Stock to Insider Exit Prices
NEW YORK, November 6 —
Even as IMAX Corporation (IMAX) reported record Q3 adjusted EPS of $2.21, a 116.4% beat over the $1.02 analyst consensus, the stock sits at $47.27, below every price at which its CEO and other senior executives sold a combined $29 million of shares in the two months before those results landed.
- Q3 2026 adjusted EPS of $2.21 beat the $1.02 consensus by 116.4%; record global box office of $712 million.
- Record adjusted EBITDA of $121 million at a 69% margin on $174.55 million in record revenue.
- Net insider sales of $29.09 million over 90 days; shares at $47.27 versus a $60 analyst consensus target.
Platform Leverage Is Not the Problem
IMAX's DMR technology digitally remasters films into its proprietary format for a global network spanning commercial multiplexes, museums, and theme parks across six markets. With "The Odyssey" as a key Q3 driver, the platform generated $712 million in global box office, translating $174.55 million in revenue into $121 million in adjusted EBITDA, a 69% margin that shows how efficiently the technology-licensing model converts a strong content cycle into cash. The company signed 105 new system locations year-to-date per its Q3 8-K, and trailing twelve-month revenue growth of 63.7% and $151 million in operating cash flow confirm the platform is gaining rather than defending ground.
Six Sellers, No Buyers
CEO Richard Gelfond sold $23.98 million across three consecutive days in August 2026: 151,253 shares at $51.00 on August 18, 205,504 shares at $53.27 on August 19, and 100,000 shares at $53.23 on August 20. Other senior executives filed their own open-market sales through September 10. Net insider transactions over the 90-day period totaled $29.09 million sold against zero purchases. IMAX shares now trade at $47.27, below Gelfond's lowest exit price of $51.00, a gap the record quarter has not closed.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| IMAX | $2.6B | 20.4x | +39.6% |
| CNK | $4.5B | 13.8x | +40.1% |
| LYV | $41.1B | 92.7x | +29.0% |
| PLAY | $271M | n/a | -41.9% |
| AMCX | $354M | 3.3x | +12.1% |
| MCS | $841M | 31.4x | +78.3% |
The Q4 Print That Settles It
The analyst consensus target of $60 against the current price implies a 27% premium, and four consecutive estimate beats escalating from 23.3% to 116.4% argue the earnings engine is systematically underestimated. The number that settles the debate is Q4 adjusted EPS: a print near or above the $2.21 Q3 record would confirm that quarter as a floor and force a reappraisal of why insiders sold shares at prices the stock has yet to reclaim. The DCF calculator can stress-test those margin assumptions. Run the free IMAX Corporation deep-dive for the latest numbers.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
What were IMAX's Q3 2026 earnings?
IMAX reported record adjusted EPS of $2.21 in Q3 2026, beating the $1.02 analyst consensus by 116.4%. The company posted record revenue of $174.55 million with adjusted EBITDA of $121 million at a 69% margin and record global box office of $712 million.
Why did IMAX insiders sell shares before earnings?
Between August 18 and September 10, CEO Richard Gelfond executed three open-market sales totaling $23.98 million at prices ranging from $51.00 to $53.27 per share, while other senior executives filed their own sales. Net insider transactions over the 90-day period reached $29.09 million in sales against zero purchases.
Where is IMAX stock trading relative to insider exit prices?
IMAX shares trade at $47.27, below Gelfond's lowest sale price of $51.00 and well below the $53.27 high from his August 19 sale. The gap remains despite the record quarterly earnings beat.
What is the analyst consensus price target for IMAX?
The analyst consensus target is $60 per share, implying a 27% premium to the current $47.27 stock price. Four consecutive quarters of escalating earnings beats, from 23.3% to 116.4%, suggest the earnings engine is systematically underestimated.
How does IMAX's technology-licensing model work?
IMAX's DMR technology digitally remasters films into its proprietary format across a global network spanning commercial multiplexes, museums, and theme parks in six markets. The platform signed 105 new system locations year-to-date and generated trailing twelve-month revenue growth of 63.7% with $151 million in operating cash flow.
IMAX filed an 8-K on November 5, 2026 reporting record third-quarter results including adjusted EPS of $2.21 that beat analyst estimates by 116.4%. The stock sits at $47.27—below every price at which its CEO and five other senior insiders sold a combined $29 million worth of shares just two months earlier.